These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 9718196)
1. The estrogen receptor's involvement in osteoblasts' adaptive response to mechanical strain. Damien E; Price JS; Lanyon LE J Bone Miner Res; 1998 Aug; 13(8):1275-82. PubMed ID: 9718196 [TBL] [Abstract][Full Text] [Related]
2. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I. Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572 [TBL] [Abstract][Full Text] [Related]
3. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females. Damien E; Price JS; Lanyon LE J Bone Miner Res; 2000 Nov; 15(11):2169-77. PubMed ID: 11092397 [TBL] [Abstract][Full Text] [Related]
4. Mechanical strain stimulates ROS cell proliferation through IGF-II and estrogen through IGF-I. Cheng Mz; Zaman G; Rawlinson SC; Mohan S; Baylink DJ; Lanyon LE J Bone Miner Res; 1999 Oct; 14(10):1742-50. PubMed ID: 10491222 [TBL] [Abstract][Full Text] [Related]
5. Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. Jessop HL; Suswillo RF; Rawlinson SC; Zaman G; Lee K; Das-Gupta V; Pitsillides AA; Lanyon LE J Bone Miner Res; 2004 Jun; 19(6):938-46. PubMed ID: 15190886 [TBL] [Abstract][Full Text] [Related]
6. Mechanical strain activates estrogen response elements in bone cells. Zaman G; Cheng MZ; Jessop HL; White R; Lanyon LE Bone; 2000 Aug; 27(2):233-9. PubMed ID: 10913916 [TBL] [Abstract][Full Text] [Related]
7. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin. Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921 [TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism. Wong C; Lai T; Hilly JM; Stewart CE; Farndon JR Surgery; 2002 Dec; 132(6):998-1006; discussion 1006-7. PubMed ID: 12490847 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780. Chan TW; Pollak M; Huynh H Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Huynh HT; Pollak M Cancer Res; 1993 Dec; 53(23):5585-8. PubMed ID: 8242606 [TBL] [Abstract][Full Text] [Related]
12. Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. Zaman G; Jessop HL; Muzylak M; De Souza RL; Pitsillides AA; Price JS; Lanyon LL J Bone Miner Res; 2006 Aug; 21(8):1297-306. PubMed ID: 16869728 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators. Fuchs-Young R; Howe S; Hale L; Miles R; Walker C Mol Carcinog; 1996 Nov; 17(3):151-9. PubMed ID: 8944075 [TBL] [Abstract][Full Text] [Related]
14. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats. Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. Robertson JF; Nicholson RI; Bundred NJ; Anderson E; Rayter Z; Dowsett M; Fox JN; Gee JM; Webster A; Wakeling AE; Morris C; Dixon M Cancer Res; 2001 Sep; 61(18):6739-46. PubMed ID: 11559545 [TBL] [Abstract][Full Text] [Related]
16. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Pratt SE; Pollak MN Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat. Dipippo VA; Powers CA J Pharmacol Exp Ther; 1997 Apr; 281(1):142-8. PubMed ID: 9103491 [TBL] [Abstract][Full Text] [Related]
18. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone. Sibonga JD; Bell NH; Turner RT J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. Chiarenza A; Lazarovici P; Lempereur L; Cantarella G; Bianchi A; Bernardini R Cancer Res; 2001 Apr; 61(7):3002-8. PubMed ID: 11306479 [TBL] [Abstract][Full Text] [Related]
20. Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures. Méndez-Dávila C; García-Moreno C; Turbì C; de la Piedra C J Endocrinol Invest; 2004 Nov; 27(10):904-12. PubMed ID: 15762036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]